Welcome to LookChem.com Sign In|Join Free
  • or
3-[4-(3-Phenyl-propylsulfanyl)-[1,2,5]thiadiazol-3-yl]-pyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

169542-77-2

Post Buying Request

169542-77-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

169542-77-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 169542-77-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,5,4 and 2 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 169542-77:
(8*1)+(7*6)+(6*9)+(5*5)+(4*4)+(3*2)+(2*7)+(1*7)=172
172 % 10 = 2
So 169542-77-2 is a valid CAS Registry Number.

169542-77-2Downstream Products

169542-77-2Relevant academic research and scientific papers

Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation

Sauerberg, Per,Jeppesen, Lone,Olesen, Preben H.,Sheardown, Malcolm J.,Fink-Jensen, Anders,Rasmussen, Thoger,Rimvall, Karin,Shannon, Harlan E.,Bymaster, Frank P.,DeLapp, Neil W.,Calligaro, Dave O.,Ward, John S.,Whitesitt, Celia A.,Thomsen, Christian

, p. 2897 - 2902 (2007/10/03)

Series of analogs to the functional m1 selective agonist, xanomeline (hexyloxy-TZTP), were evaluated for their in vitro ml efficacy in cell lines transfected with the human m1 receptor. Systematic variation of the side chain and the azacyclic ring led to the discovery of potent muscarinic agonists with robust m1 efficacy, all having the phenylpropargyloxy/thio as the side chain. The most selective compound was the phenylpropargylthio- [3.2.1] endo analog 28, which is a potent and efficacious m1 agonist with no m2 activity.

Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: Potential application for the treatment of irritable bowel syndrome

Mitch, Charles H.,Brown, Thomas J.,Bymaster, Frank P.,Calligaro, David O.,Dieckman, Donna,Merrit, Leander,Peters, Steven C.,Quimby, Steven J.,Shannon, Harlan E.,Shipley, Lisa A.,Ward, John S.,Hansen, Kristian,Olesen, Preben H.,Sauerberg, Per,Sheardown, Malcolm J.,Swedberg, Michael D. B.,Suzdak, Peter,Greenwood, Beverley

, p. 538 - 546 (2007/10/03)

Irritable bowel syndrome (IBS) is a pathophysiolocal condition characterized by abnormal bowel habits that are frequently accompanied by abdominal pain. Current therapy based on reducing high-amplitude GI contractions with nonselective muscarinic antagoni

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 169542-77-2